[HTML][HTML] Oxidative stress–Complex pathological issues concerning the hallmark of cardiovascular and metabolic disorders

D Rotariu, EE Babes, DM Tit, M Moisi, C Bustea… - Biomedicine & …, 2022 - Elsevier
Oxidative stress is a complex biological process characterized by the excessive production
of reactive oxygen species (ROS) that act as destroyers of the REDOX balance in the body …

Uric acid and cardiovascular disease: an update from molecular mechanism to clinical perspective

W Yu, JD Cheng - Frontiers in pharmacology, 2020 - frontiersin.org
Uric acid (UA) is the end product of purine nucleotide metabolism in the human body.
Hyperuricemia is an abnormally high level of UA in the blood and may result in arthritis and …

EULAR recommendations for cardiovascular risk management in rheumatic and musculoskeletal diseases, including systemic lupus erythematosus and …

GC Drosos, D Vedder, E Houben, L Boekel… - Annals of the …, 2022 - ard.bmj.com
Objective To develop recommendations for cardiovascular risk (CVR) management in gout,
vasculitis, systemic sclerosis (SSc), myositis, mixed connective tissue disease (MCTD) …

2020 American College of Rheumatology guideline for the management of gout

JD FitzGerald, N Dalbeth, T Mikuls… - Arthritis & …, 2020 - Wiley Online Library
Objective To provide guidance for the management of gout, including indications for and
optimal use of urate‐lowering therapy (ULT), treatment of gout flares, and lifestyle and other …

Hyperuricaemia and gout in cardiovascular, metabolic and kidney disease

C Borghi, E Agabiti-Rosei, RJ Johnson… - European journal of …, 2020 - Elsevier
During the last century, there has been an increasing prevalence of hyperuricaemia noted in
many populations. While uric acid is usually discussed in the context of gout …

[HTML][HTML] Update on the epidemiology, genetics, and therapeutic options of hyperuricemia

L Li, Y Zhang, C Zeng - American journal of translational research, 2020 - ncbi.nlm.nih.gov
Hyperuricemia may occur when there is an excess of uric acid in the blood. Hyperuricemia
may result from increased production or decreased excretion of uric acid. Elevated uric acid …

Excess comorbidities in gout: the causal paradigm and pleiotropic approaches to care

HK Choi, N McCormick, C Yokose - Nature Reviews Rheumatology, 2022 - nature.com
Gout is a common hyperuricaemic metabolic condition that leads to painful inflammatory
arthritis and a high comorbidity burden, especially cardiometabolic-renal (CMR) conditions …

Febuxostat for cerebral and cardiorenovascular events prevention study

S Kojima, K Matsui, S Hiramitsu, I Hisatome… - European heart …, 2019 - academic.oup.com
Aims To compare the occurrence of cerebral, cardiovascular, and renal events in patients
with hyperuricaemia treated with febuxostat and those treated with conventional therapy with …

The case for uric acid-lowering treatment in patients with hyperuricaemia and CKD

Y Sato, DI Feig, AG Stack, DH Kang… - Nature Reviews …, 2019 - nature.com
Hyperuricaemia is common among patients with chronic kidney disease (CKD), and
increases in severity with the deterioration of kidney function. Although existing guidelines …

Uric acid as a risk factor for chronic kidney disease and cardiovascular disease―Japanese guideline on the management of asymptomatic hyperuricemia―

I Hisatome, P Li, J Miake, F Taufiq, E Mahati… - Circulation …, 2021 - jstage.jst.go.jp
Serum uric acid (UA) is taken up by endothelial cells and reduces the level of nitric oxide
(NO) by inhibiting its production and accelerating its degradation. Cytosolic and plasma …